Package 70069-272-05

{"route": ["INTRAVENOUS"], "spl_id": "6d4f205d-626c-4285-ba7b-c0ca536c7875", "openfda": {"upc": ["0370069272015", "0370069273012", "0370069271018"], "unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["50131bbc-ad43-4708-946f-e4000828137c"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL in 1 CARTON (70069-272-05)  / 4 mL in 1 VIAL", "package_ndc": "70069-272-05", "marketing_start_date": "20180618"}, {"sample": false, "description": "25 VIAL in 1 CARTON (70069-272-25)  / 4 mL in 1 VIAL (70069-272-01)", "package_ndc": "70069-272-25", "marketing_start_date": "20180618"}], "brand_name": "Verapamil Hydrochloride", "product_id": "70069-272_6d4f205d-626c-4285-ba7b-c0ca536c7875", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "70069-272", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Somerset Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA211015", "marketing_category": "ANDA", "marketing_start_date": "20180618", "listing_expiration_date": "20261231"}